We examined the influence of nitric oxide (NO) on normal and collateral cerebral blood flow after occlusion of the middle cerebral artery (MCA). Effects of AP-nitro-L-arginine (nitro arginine) , an inhibitor of NO synthase, were examined during normotension and hy potension (arterial pressure, 50 mm Hg) in 49 anesthe tized dogs. Following a craniotomy, a branch of the MCA was cannulated, and collateral-dependent tissue was identified using the shadow-flow technique. Regional ce rebral blood flow was measured with microspheres, and pial artery pressure was measured with a micropipette. Intravenous nitroarginine reduced blood flow to normal cerebrum by approximately 40% (p < 0.05) during nor motension and hypotension, with aortic pressure main tained constant after nitroarginine administration. Injec tion of nitroarginine during hypotension, without control of pressor effects, increased aortic and pial artery pres-
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We examined the influence of nitric oxide (NO) on normal and collateral cerebral blood flow after occlusion of the middle cerebral artery (MCA). Effects of AP-nitro-L-arginine (nitro arginine) , an inhibitor of NO synthase, were examined during normotension and hy potension (arterial pressure, 50 mm Hg) in 49 anesthe tized dogs. Following a craniotomy, a branch of the MCA was cannulated, and collateral-dependent tissue was identified using the shadow-flow technique. Regional ce rebral blood flow was measured with microspheres, and pial artery pressure was measured with a micropipette. Intravenous nitroarginine reduced blood flow to normal cerebrum by approximately 40% (p < 0.05) during nor motension and hypotension, with aortic pressure main tained constant after nitroarginine administration. Injec tion of nitroarginine during hypotension, without control of pressor effects, increased aortic and pial artery pres-Inhibition of nitric oxide (NO) synthase produces constriction of cerebral blood vessels (Faraci, 1990; Katusic and Vanhoutte, 1990; Rosenblum et aI., 1990) . Although the cerebral vascular response to inhibitors of NO synthase under normal conditions has received considerable attention, the effects of inhibition of NO synthase on blood flow to areas of cerebrum that are dependent on collateral flow after occlusion of an artery are not known.
It has been suggested that inhibition of NO pro duction may be beneficial during ischemia (Nowicki et aI., 199 1; Buisson et aI., 1992; Nagafuji et al., sure approximately twofold. Concurrently, blood flow to normal cerebrum decreased (p < 0.05), while flow to col lateral-dependent cerebrum increased (p < 0.05). Phe nylephrine was infused during hypotension to increase arterial pressure to values similar to those achieved fol lowing nitroarginine. Blood flow to collateral-dependent cerebrum increased (p < 0.05), but flow to normal cere brum was not altered during infusion of phenylephrine. Thus, inhibition of NO synthase during hypotension in creases arterial pressure, decreases blood flow to normal cerebrum, and increases blood flow to collateral dependent cerebrum. Phenylephrine also increases perfu sion pressure and blood flow to collateral-dependent ce rebrum, but in contrast to nitroarginine, it does not redis tribute blood flow from normal cerebrum. Key Words: Cerebral blood flow-Collateral circulation-Nitric ox ide-Phenylephrine-Dogs. 1992; Nishikawa et aI., 1993) and in anaphylactic (Amir and English, 199 1) , septic (Nava et aI., 199 1) , and hemorrhagic shock (Szabo et aI., 1992) . Effects of inhibition of NO synthase on collateral cerebral blood flow (CBF) during hypotension, however, are not known. A potential concern is that cerebral va soconstrictor effects of NO synthase inhibitors might be harmful when hypotension is present dur ing cerebral ischemia.
We examined effects of �-nitro-L-arginine (ni troarginine), an inhibitor of NO synthase, on blood flow to normal and collateral-dependent cerebrum. Effects of nitro arginine were examined during nor motension and hypotension. We anticipated that in hibition of NO synthase might constrict cerebral vessels and increase resistance of collateral vessels, thereby reducing blood flow to collateral-dependent cerebrum. Because a decrease in perfusion pressure may reduce flow to collateral-dependent cerebrum (Muhonen et aI., 1992) , an alternative possibility was that elevation of perfusion pressure might in crease blood flow to collateral-dependent cere brum, despite a reduction in flow to normal cere brum.
Two novel approaches were used in this study. First, we used a technique that separates collateral flow from overlap flow and thus identifies the area of brain that is dependent on collateral flow for postocclusion protection (Loftus et al., 1990; Mu honen et al., 1992) . This method allowed compari son of effects of inhibition of NO synthase on col lateral and normal brain blood flow during hypoten sion and normotension. Second, we measured pressure in occluded and normal branches of the middle cerebral artery (MeA) using a micropipette and servo-null device. These resultant data enabled us to calculate the resistance of large cerebral ar teries, small vessels, and collateral vessels.
MATERIALS AND METHODS
Forty-nine mongrel dogs weighing 19-26 kg were anes thetized with thiopental sodium (25 mg/kg i. v.), and their tracheas were intubated. Anesthesia was maintained with 1% halothane and a 45% O2-55% N20 mixture (Harvard pump respirator, Harvard Apparatus, Millis, MA, U.S.A.). Core temperature, measured with a Swan-Ganz catheter in the pulmonary artery, was 38.5 ± O.03°C and did not change significantly during interventions. Cathe ters were placed in femoral and brachial arteries for with drawal of reference blood samples, in a brachial artery for measurement of arterial pressure, and in a femoral vein for administration of fluid and drugs. Blood was obtained from a brachial artery catheter to measure arterial blood gases. Arterial P02 was maintained at -200 mm Hg and Pe02 at -40 mm Hg. Baseline pH was -7.30 and did not change significantly.
A 7-French pigtail catheter was introduced into the left ventricle through a femoral artery for injection of radio active microspheres to measure CBS (Buckberg et aI., 1971; Heymann et aI., 1977) . Isotopes were randomly se lected from a stock pool (153Gd, 141Ce, 113Sn, 95Nb, 85Sr, and 46SC) , and the order of injection was randomized. To measure flow, 106 microspheres (15-/-lm diameter) were injected into the left ventricle and flushed with 5 ml of saline over 5 s. The number of spheres was sufficient to assure -400 spheres per tissue sample. Reference sam ples were withdrawn from the brachial and femoral arter ies at 2.06 ml/min for a total of 2.5 min starting 30 s before injection of micro spheres (Busija et aI., 1981) .
A left frontotemporal craniotomy was performed, and after the dura over the sylvian fissure was opened, the region was superfused with artificial cerebrospinal fluid (pH, 7.31 ± 0.08; CO2, 41 ± 0.2 mm Hg; O2, 43 ± 12 mm Hg). Temperature and partial pressures of gases in the superfusate were determined at the beginning and end of perfusion and were not significantly different. The super fusate temperature was maintained at body temperature.
We studied six groups of dogs. In experimental groups 1-5, a large primary branch and a secondary branch (400-900 /-lm) of the MCA were identified. Baseline diameter of both branches was measured with a video micrometer (Colorado Video, Boulder, CO, U.S.A.). The primary branch was ligated proximally and cannulated distally with siliconized PE-50 tubing (10 cm in length). Back pressure was recorded after the tubing was secured. Pres sure in each branch was measured with a glass micropi pette (tip diameter, 2-4 /-lm) and a servo-null device (Model 5 Servo-Nulling Pressure Measuring System, In strumentation for Physiology and Medicine, San Diego, CA, U.S.A.). The tip of the micropipette was small (2-4 /-lm), allowing a nonoccluding, atraumatic puncture of vessels. The micropipette was removed from the vessel after each measurement of pressure. We have used this technique extensively.
Collateral-dependent regions of the brain were deter mined using the "shadow-flow" technique. We have pre viously described the method in detail (Loftus et aI., 1990; Greene et aI., 1992; Muhonen et aI., 1992) . Briefly, autologous heparinized blood from a reservoir was per fused through the tubing in the cannulated MCA branch using a Harvard pump (Harvard Appartus). The micropi pette was inserted in the MCA branch distal to the can nulation site. Perfusion pressure (after correction for tub ing resistance) was increased until pressures in the can nulated and normal branches of the MCA were equal. Thus, blood flow was prevented through collateral chan nels that supply the territory normally supplied by the occluded MCA branch.
The first measurement of regional cerebral blood flow (rCBF) was performed during the shadow flow. This tech nique allows separation of collateral and overlap flow components within an occluded artery. The rationale un derlying the separation of collateral flow and overlap flow has been discussed previously (Loftus et aI., 1990; Greene et aI., 1992; Muhonen et aI., 1992) , and the tech nique has been used extensively in the coronary circula tion (Hirzel et aI., 1976 (Hirzel et aI., , 1977 Harrison et aI., 1981) . Be cause the area at risk (that area identified morphologically to be supplied by the cannulated vessel) was perfused with microsphere-free blood at a pressure that prevented perfusion by collateral channels, values for rCBF during the shadow flow reflect only overlap flow from adjacent vascular beds (Hirzel et aI., 1976 (Hirzel et aI., , 1977 Harrison et aI., 1981; Loftus et aI., 1990; Green et aI., 1992; Muhonen et aI., 1992) . By studying tissue within the vascular distri bution of the cannulated MCA branch in which flow was ,,;; 10 mU100 g/min during shadow flow, identification of tissue that received primarily collateral flow with minimal contamination from overlap flow was achieved. Follow ing completion of the shadow flow, perfusion of the MCA branch was stopped so that the area at risk was once again perfused by both collateral and overlap flow.
After 30 min, a second measurement of rCBF was per formed, and the value was used as a normotensive base line. Intraluminal pressure in the cannulated and normal branches of the MCA was measured using the micropi pette, and vessel diameter was again measured. �fter this portion of the experiment, the animals were placed into one of five groups.
Nitroarginine during normotension
Group 1 (n = 6) was studied during normotension [mean arterial pressure (MAP), 105 ± 14 mm Hg (mean ± SD)]. Each animal received an infusion of nitroarginine, 5 mg/kg i.v., over 5 min. An average of 700 ml of blood was withdrawn to maintain MAP within 5 mm Hg of baseline. Regional cerebral blood flow was measured 20 and 40 min after infusion of nitroarginine. Prior to each measurement of blood flow, intraluminal pressure and MCA branch diameter were measured in the cannulated and normal MCA branches.
Group 2 (n = 6) was given nitroarginine as described for group 1. Following infusion of nitroarginine, however, the pressor effect was not prevented by hemorrhage as in group 1. In group 2, blood flow, MCA branch diameter, and pial artery pressure (normal and cannulated branches of MCA) were measured 20 and 40 min after injection of nitroarginine.
Nitroarginine during hypotension
In group 3 (n = 8), following measurement of blood flow during normotension, MAP was reduced to 50 mm Hg by removal of approximately 600 ml of blood. After MAP was stabilized at 50 mm Hg for 30 min, we mea sured blood flow, normal MCA branch diameter, and pressure in normal and cannulated MCA branches. These measurements were used as baseline values during hy potension. During and after infusion of nitroarginine over 5 min, the pressor response to nitroarginine was pre vented by withdrawal of -500 ml blood, in addition to the 600 ml withdrawn to produce hypotension. Blood flow, pial artery pressure (normal and cannulated branches of MCA), and pial artery diameter were measured 20 and 40 min after injection of nitroarginine.
In group 4 (n = 9), blood was removed to reduce base line MAP to 50 mm Hg before infusion of nitoarginine. Group 4 was given nitro arginine during hypotension, as described for group 3, but the pressor effect of nitroargi nine was not prevented by hemorrhage as in group 3. At 20 and 40 min after infusion of nitroarginine, measure ments were performed as described for groups 1-3.
Phenylephrine during hypotension
In group 5 (n = 6), we produced an increase in arterial pressure after hypotension was produced by hemorrhage; this increase was similar in magnitude to the increase in pressure after nitroarginine in group 4. Blood flow, pial artery pressure (normal and cannulated branches of MCA), and pial artery diameter were measured during hypotension and 20 and 40 min after beginning an infusion of phenylephrine (Sigma Chemical, St Louis, MO, U.S.A.) at a rate of -3 f.Lg/min i.v.
Identification of area at risk
At the end of each experiment in groups 1-5, the can nulated branch of the MCA was again perfused at the pressure measured in the normal MCA branch (similar to shadow flow), thereby preventing blood flow through col lateral channels. Fifty milliliters of 4% neutral red dye (Fisher Scientific, Fair Lawn, NJ, U.S.A.) was injected into the femoral vein and allowed to circulate for 2 min, creating a negative map of the area at risk. This approach is similar to one employed previously in the brain and heart Heistad, 1986, 1987; Loftus et aI., 1987) . The animals were killed with pentobarbital (300 mg/kg i.v.), and the cerebrum and cerebellum were removed, sectioned in the midline, and sliced into 3-mm coronal sections. The area at risk (defined morphologically by the absence of staining by neutral red) was dissected from the surrounding tissue and divided into uniform tissue sam ples of 0.4-0.5 g. Similar samples were taken from ipsi lateral normal cortex outside of the risk area and cerebel lum. The tissue samples were weighed, and along with J Cereb Blood Flow Metab, Vol. 14, No. 5, 1994 reference blood samples, they were counted in a 3-in well-type 'Y counter for 5 min each.
Effects of nitroarginine on cerebral metabolic rate of oxygen during hypotension
In 14 dogs (group 6), the cerebral metabolic rate of oxygen (CMR02) was measured to assess effects of ni troarginine on cerebral metabolism during hypotension. A left-sided craniectomy was performed, and the brain was perfused with artificial cerebrospinal fluid, as in groups 1-5. A 26-g Teflon catheter was inserted into the sagittal sinus. A branch of the MCA was dissected free from surrounding arachnoid, and intraluminal pressure and diameter were measured; this branch was not per fused or occluded in these experiments. Total O2 content was measured (Lex02con, Hospex Fiberoptics, Chestnut Hill, MA, U.S.A.) in arterial and sagittal sinus blood sam ples to determine the arteriovenous (A V) oxygen differ ence (measured as percentage of volume). The CMR02 was calculated as the product of the A V O2 difference multiplied by CBF. Blood was removed to reduce MAP to 50 mmHg, and hypotension was maintained for 30 min. Blood flow, pial artery pressure and diameter, and A V O2 difference was again measured. As in group 4, nitroargi nine was administered (5 mg/kg i.v.), and blood pressure was allowed to rise. Blood flow, pial artery pressure and diameter, and A V O2 difference were measured 20 and 40 min after injection of nitroarginine. The animals were killed and tissue samples were removed, weighed, and counted.
Calculation of resistance
Resistance of small vessels in normal cerebrum was calculated as normal MCA branch pressure/rCBF. Col lateral resistance was calculated from the following equa tion: (pressure in normal MCA branch -pressure in can nulated MCA branch)IrCBF to collateral-dependent re gion. Large-artery resistance was calculated as (aortic pressure -pressure in normal MCA branch)/rCBF to normal brain.
Statistical analysis
Values are expressed as means ± SD. Flow, resis tance, pressure, and vessel diameter were compared within groups by the Duncan multiple-range test. In groups 1 and 2, the values at 20 and 40 min following nitroarginine were compared with the normotension value, and in groups 3-6, the 20 and 40 min values were compared with the hypotensive baseline value; p < 0.05 was considered to be statistically significant.
RESULTS

Nitroarginine during normotension
Nitroarginine produced a global decrease in blood flow to normal cerebrum by �40% when the pressor effect of nitro arginine was prevented in group I (Table 1) . Flow to collateral-dependent ce rebrum tended to decrease following nitroarginine. Small-vessel resistance in normal brain increased after nitro arginine (Table 1) , but large-artery and collateral resistance did not change significantly. Values are means ± SD in six dogs. Value for normal cerebral hemisphere indicates flow ipsilateral to MCA cannulation (excluding flow to risk area). Increases in systemic pressure after nitroarginine were prevented by withdrawal of blood. Baseline pH was 7.27 ± 0.03; PaOZ was 210 ± 9; and Paco2 was 40 ± I; none changed significantly after nitroarginine. Pial artery diameter was measured in a normal MCA branch, in which pressure was measured with a micropipette, adjacent to the cannulated branch. Baseline diameter of the cannulated MCA branch was 681 ± 127 /-Lm. a p < 0.05 compared with baseline value.
Nitroarginine during normotension without prevention of pressor effects
Nitroarginine increased systemic blood pressure �20% and MCA pressure �40% in group 2 ( Fig. 1 and Table 2 ; p < 0.05). Despite the increase in sys temic and pial artery perfusion pressure, blood flow to normal cerebrum decreased significantly follow ing nitro arginine ( Fig. 1 ; p < 0.05). Collateral dependent blood flow tended to decrease. Resis tance of small vessels in normal cerebrum increased after nitroarginine (Table 2 ; p < 0.05), but large artery and collateral resistance were largely un changed.
Nitroarginine during hypotension
When systemic pressure was maintained at 50 mm Hg following nitroarginine, MCA pressure re mained essentially unchanged in group 3 (Table 3) . After nitroarginine, blood flow to normal cerebrum decreased �35% (Table 3 ; p < 0.05), and blood flow to collateral-dependent tended to decrease. After nitroarginine, resistance of normal brain small ves sels increased (Table 3 ; p < 0.05), while collateral and large-vessel resistance tended to increase.
Nitroarginine during hypotension without prevention of pressor effects
During hypotension, nitroarginine increased sys temic blood pressure � 70% and MCA pressure greater than twofold in group 4 (Table 4 and Fig. 2 ; p < 0.05). These increases were associated with a significant decrease in blood flow to normal cere brum but a significant increase in blood flow to col lateral-dependent cerebrum (Table 4 and Fig. 2) . Resistance in normal brain small vessels and large arteries increased (Table 4 and Fig. 2) , while collat eral resistance did not change significantly.
Effects of phenylephrine
During hypotension, infusion of phenylephrine increased arterial pressure to levels similar to that produced by nitro arginine in group 5. Blood flow to normal cerebrum was unchanged, but collateral blood flow increased in response to phenylephrine (Table 5 and Fig. 2 ; P < 0.05). Collateral resistance did not change during phenylephrine administration (Table 5 ). In contrast, small-vessel resistance in creased significantly ( Table 5 ; p < 0.05), and large vessel resistance tended to increase.
Effects of nitroarginine on cerebral metabolic rate of oxygen
There was no significant change in CMR02 dur ing hypotension in group 6 ( Table 6) . At 20 and 40 min after nitroarginine, CMR02 tended to increase but the change was not significant (Table 6 ; p > 0.05). Thus, the decrease in CBF following ni troarginine during hypotension was not secondary to a decrease in cerebral metabolism but rather to a direct effect on cerebral blood vessels.
DISCUSSION
Several studies have addressed effects of inhibi tion of NO synthase on normal blood vessels (Faraci, 1990, 199 1; Gardiner et aI., 1990 Gardiner et aI., , 1991 Ka tusic and Vanhoutte, 1990; Tanaka et aI., 1991; Szabo et aI., 1992) . However, effects on collateral dependent cerebral vessels have not been previ- ously studied. There are two major new findings in the present study. First, collateral flow is substan tially increased following nitroarginine and phenyl ephrine administration during hypotension. Sec- Vol. 14, No. 5, 1994 ond, in contrast to collateral flow, blood flow to normal cerebrum decreased after nitroarginine and was unchanged after phenylephrine. Thus, although nitroarginine reduces blood flow to normal cere brum during both normotension and hypotension, it increases flow to collateral-dependent cerebrum during hypotension. Our findings with phenyleph rine suggest that this beneficial effect on blood flow to collateral-dependent cerebrum is related primar ily to an increase in perfusion pressure.
Consideration of the method
This model of collateral cerebral circulation was developed to allow study of tissues that are depen dent on collateral flow, with minimal contamination by overlap flow (Loftus et aI., 1990) . Collateral and normal vessels may respond differently to interven tions (Greene et aI., 1992; Muhonen et aI., 1992) , and it is important to differentiate the response of collateral vessels from the responses of normal overlap vessels when studying tissue at risk for ischemia following arterial occlusion.
The model utilized in the present study requires cannulation and occlusion of a major branch of the MCA. Despite this vascular manipulation, reactiv ity of the cerebral vascular bed appeared to be in tact. In previous studies, cerebral vessels dilated in response to hypercarbia and seizures (Muhonen et aI., 1994) and to topical adenosine (unpublished data). In this study, we examined responses to sys temic vasoconstrictors (nitroarginine and phenyl ephrine), and it appeared that vascular responses to these stimuli are preserved.
There are several limitations of the present model. First, measurement of pressure in branches of the MCA limits the precision of the calculated value of collateral resistance. Such values include not only resistance of collateral vessels, but also resistance of arteries between the point of measure ment and the origin of collateral vessels. Although the calculation is not precise, it probably reflects the direction of changes accurately. Second, changes in small-vessel resistance were calculated, but because the segment of vessels that causes small-vessel resistance is heterogeneous (and in cludes arterioles, capillaries, and venules), we could not precisely localize where changes in small vessel resistance occurred. Third, CMR02 repre sents a global value and does not reflect regional differences within the cerebrum. The CMR02 was measured in normal cerebrum, and the approach does not allow measurement of CMR02 in collat eral-dependent cerebrum. Finally, it is not clear whether the findings in dogs can be extrapolated to humans. In these experiments, blood flow to cere- Values are means ± SD in six dogs. Value for normal cerebral hemisphere indicates flow ipsilateral to MCA cannulation (excluding flow to risk area). Baseline pH was 7.30 ± 0.03; PaOZ was 194 ± 10; and PaCOZ was 40 ± 1; none changed significantly after nitroarginine. Pial atery diameter was measured in a normal MCA branch, in which pressure was measured with a micropipette, adjacent to the cannulated branch. Baseline diameter of the cannulated MCA branch was 630 ± 102 fLm. a p < 0.05 compared with baseline value.
brum was not affected when a branch of the MeA was occluded. This response may be different in humans, who are prone to develop cerebral infarc tion following arterial occlusion. Both humans and dogs have extensive collateral circulation through pial anastomoses (Thompson and Smith, 195 1) , and we are not aware of important differences in intra cranial collateral vessels. It is not clear whether susceptibility of humans to development of infarc tion after arterial occlusion is related to unrecog nized differences in vascular anatomy, to superim posed vascular disease in humans, and/or to other factors. Thus, although anesthetized dogs may be an appropriate model for study of cerebral collateral vessels, one must be cautious in extrapolating re sults to humans, especially in the presence of vas cular disease.
Augmentation of collateral flow by inhibition of nitric oxide synthase
Blood flow to collateral-dependent cerebrum was augmented by nitroarginine during hypotension when systemic blood pressure was not controlled (group 4). Nitroarginine increased pital artery pres sure in the cannulated MeA branch and in the nor mal MeA branch. This increase in perfusion pres sure was, however, associated with a decrease in flow to normal cerebrum. Thus, the response to ni- Values are means ± SD in eight dogs. Value for normal cerebral hemisphere indicates flow ipsilateral to MCA cannulation (excluding flow to risk area). Increases in systemic pressure after nitroarginine were prevented by withdrawal of arterial blood. Baseline pH was 7.29 ± 0.03; PaCOZ was 212 ± 12; and PaCOZ was 40 ± 1; none changed significantly after nitroarginine. Pial artery diameter was measured in a normal MCA branch, in which pressure was measured with a micropipette, adjacent to the cannulated branch. Baseline diameter of the cannulated MCA branch was 648 ± 138 fLm. a p < 0.05 compared with hypotension value. Values are means ± SD in nine dogs. Value for normal cerebral hemisphere indicates flow ipsilateral to MCA cannulation (excluding flow to risk area). Baseline pH was 7.28 ± 0.04; P a02 was 205 ± 17; and P aco2 was 40 ± 1; none changed significantly after nitroarginine. Pial artery diameter was measured in a normal MCA branch, in which pressure was measured with a micropipette, adjacent to the cannulated branch. Baseline diameter of the cannulated MCA branch was 684 ± 207 fLm. a p < 0.05 compared with hypotension value.
troarginine reflects a redistribution of normal cere bral flow through collateral vessels. This redistribu tion of blood flow could represent an "inverse steal" phenomenon, secondary to increased perfu sion pressure to the risk area in which blood flow is pressure-dependent. During focal cerebral isch emia, barbiturates (Branston et aI., 1979; Ochiai et aI., 1982) and hypocapnia (Soloway et aI., 1968; Kogure et aI., 1969; Yamaguchi et aI., 1971) in crease blood flow to ischemic tissue following arte rial occlusion. This redistribution of flow may be produced by either a reduction in metabolic rate in normal cerebrum by barbiturates or by vasocon striction in normal cerebrum by hypocapnia.
Prior to the present study, effects of NO on au toregulation of blood flow to collateral-dependent cerebrum were not known. Our studies indicate that inhibition of NO has different effects on blood flow to collateral-dependent cerebrum during normoten sion and during hypotension. There are several pos sible explanations for altered responses of the col lateral vasculature to nitroarginine during hypoten sion. First, autoregulation is impaired in collateral dependent tissue during hypotension following cerebral artery occlusion (Muhonen et aI., 1992) . Flow in this region is therefore directly dependent on perfusion pressure of collateral vessels. Aug mentation of perfusion pressure by nitroarginine would be expected to increase collateral flow if autoregulation were impaired. During normoten sion without control of the pressor effects of ni troarginine, a significant increase in MeA perfusion pressure was associated with a decrease in collat eral-dependent flow (Table 2) . Thus, flow to the collateral-dependent zone was not dependent on Vol. 14, No.5, 1994 perfusion pressure during normotension, which suggests that autoregulation within the collateral dependent bed was maintained. In contrast, during hypotension, administration of nitro arginine with out prevention of pressor response produced an in crease in MeA perfusion pressure and an increase in flow to collateral-dependent cerebrum. When systemic pressure was controlled (group 3), MeA pressure did not change, and flow to collateral dependent cerebrum did not increase. Thus, flow to the collateral-dependent tissue was dependent on perfusion pressure during hypotension, which sug gests that autoregulatory capacity was exceeded or impaired within the collateral bed. Previous studies have shown that collateral-dependent flow in dogs is directly dependent on perfusion pressure only at low pressures-i.e., pial artery pressures <30 mm Hg (Muhonen et aI., 1992) . In the present study, pial artery pressure was � 30 mm Hg during hy potension, and thus the autoregulatory dilator ca pacity of collateral vessels may have been exceeded.
A second possible reason for increases in collat eral flow during the inhibition of NO synthase could be the preferential site of action of NO. During both normotension and hypotension, nitroarginine in creased resistance of small vessels more than large vessels. These findings suggest that basal release of NO is greatest in small vessels. Differences in the role of basal NO formation in the larger cerebral arteries and in small cerebral arterioles have been previously studied, and the differences are not com pletely understood. Several studies suggest that in hibitors of NO synthase aff ect large cerebral vessels (Rosenblum, 1986; Kontos et aI., 1988; Watanabe et aI., 1988; Busija et aI., 1990; Faraci, 1990; et aI., 199 1). Our studies suggest that inhibition of NO synthase was greater at the small-vessel level than at the large-vessel level. If cerebral collaterals are primarily at the level of small vessels, we would have expected significant inhibition of collateral-dependent flow during ni troarginine. Previous studies, however, suggest that the sites of origin of canine collateral channels are in large part at the level of large pial arteries and not principally at the level of microvascular anasto moses (Loftus et aI., 1990; Greene et aI., 1992) . Thus, the collateral vasculature may be relatively unresponsive to inhibition of NO, as in the present study.
The role of NO in cerebral ischemia has not been resolved. In other models of permanent MCA oc clusion, inhibition of NO synthase appears to be neuroprotective initially, with reduction of infarct volumes compared with controls (Nowicki et aI., 199 1; Buisson et aI., 1992; Nagafuji et aI., 1992; Nishikawa et aI., 1993) . The mechanism for the neu roprotective effects has been proposed to be en hancement of perfusion (Pelligrino, 1993) . In the present study, perfusion of the risk area following arterial occlusion was augmented by inhibition of NO synthase. An increase in perfusion pressure contributed to redistribution of blood flow from normal cerebral tissue to the risk area.
Some studies have suggested that inhibition of NO synthase increases infarct volume. After sev eral hours (or perhaps 24 h) of ischemia, NO may assume a neurotoxic role (Dawson et aI., 1992; Ya mamoto et aI., 1992; Zhang and Iadecola, 1993) . Toxicity may be mediated by inducible NO syn thase. As ischemia following arterial occlusion is prolonged, NO production may be augmented, pos sibly through release of cytokines (Feuerstein et aI., 1993) . NO can combine with superoxide anion to form peroxynitrite. which decomposes into the hy droxyl free radical (OH') and the nitrogen dioxide free radical (N02'), both of which are highly reac tive and potentially toxic (Beckman et aI., 1990; Radi et aI., 199 1; Pelligrino, 1993) . Free radicals may mask the potential beneficial effects of in creased perfusion of the risk area.
Augmentation of flow with phenylephrine
Phenylephrine increased perfusion pressure through collateral channels. Phenylephrine tended to increase resistance of large and small vessels, but not collateral resistance in normal cerebrum. The increase in perfusion pressure resulted in augmen tation of blood flow to collateral-dependent cere brum. Previous studies have shown that ph�nyleph rine reduces ischemia following MCA occlusion in rats but does not change normal cerebral blood flow (Drummond et aI., 1989) . In patients undergoing unilateral carotid occlusion during carotid endarter ectomy, phenylephrine increases cerebral perfusion pressure without increasing collateral vascular re sistance (Archie and Feldtman, 1989) . Thus, as in our study, phenylephrine appears to increase blood Values are means ± SD in six dogs. Value for normal cerebral hemisphere indicates flow ipsilateral to MCA cannulation (excluding flow to risk area). Baseline pH was 7.29 ± 0.03; Pao2 was 210 ± 15; and Paco2 was 39 ± 1; none changed significantly after nitroarginine. Pial artery diameter was measured in a normal MCA branch, in which pressure was measured with a micropipette, adjacent to the cannulated branch. Baseline diameter of the cannulated MCA branch was 623 ± 124 fJ.m. a p < 0.05 compared with hypotension value.
flow to collateral-dependent cerebrum following ar terial occlusion. In contrast to the effects of ni troarginine, however, there is no effect on normal cerebral blood flow.
Cerebral metabolic rate of oxygen and inhibition of synthesis of nitric oxide
This study suggests that, during hypotension, the decrease in CBF during inhibition of NO synthase was not due to a decrease in cerebral metabolism but rather to direct vasoconstrictor effects. Studies in rats have shown that inhibition of NO synthase does not affect CMR02 during normotension (Kozniewska et aI., 1992) .
Implications
This study suggests that although nitro arginine raises systemic pressure during hemorrhagic hy-potension, there is a concurrent global decrease in CBF. Thus, optimism over recent studies that have shown that inhibition of NO production may be beneficial in anaphylactic (Amir and English, 199 1) , septic (Nava et aI., 199 1) , and hemorrhagic shock (Szabo et aI., 1992) must be tempered by the poten tial consequence of reduction in cerebral flow. On the other hand, the present study indicates that dur ing hemorrhagic hypotension, there is a significant increase in blood flow to collateral-dependent cere brum following nitroarginine. Thus, although flow to normal cerebrum decreases after inhibition of NO synthase, flow to more vulnerable regions of cerebrum is increased. We speculate that the reduc tion of blood flow to normal brain tissue during ni troarginine administration with concurrent augmen tation of collateral blood flow may have clinical rel evance. 4.0 ± 1 4.2 ± 2 6.7 ± 3" 7.1 ± 3a CMROz (mll00 g-I min-I) 4.8 ± 2 4.5 ± 2 5.4 ± 2 5.5 ± 2 Pial artery diameter (fJ.) 630 ± 108 523 ± 115 574 ± 172 577 ± 175
Cerebral blood flow was calculated from the mean average of flow to the hemisphere ipsilateral to the side of the craniotomy. Values are means ± SD in 14 dogs. Baseline pH was 7.31 ± 0.03; PaOZ was 213 ± 11; and PaCOZ was 40 ± 1; none changed significantly after nitroarginine. Pial artery diameter was measured using the MCA branch in which intraluminal pressure was measured.
" p < 0.05 compared with hypotension value.
